Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Noe

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
RNA (New York, N.Y.)|November 27, 2001
Phosphorylation of the Saccharomyces cerevisiae La protein does not appear to be required for its functions in tRNA maturation and nascent RNA stabilizationK S Long, T Cedervall, C Walch-Solimena, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1989
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteersT L Chen, G B Vogelsang, B G Petty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agentE K Rowinsky, G S Long, D A Noe, et al.
Cancer Research|February 15, 1995
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantationT L Chen, J L Passos-Coelho, D A Noe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of the National Cancer Institute|December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexateA Hantel, E K Rowinsky, D A Noe, et al.
Journal of Medicinal Chemistry|March 4, 1998
The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactionsE M Shulman-Roskes, D A Noe, M P Gamcsik, et al.
Journal of the National Cancer Institute|January 18, 1989
Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamicsL B Grochow, D A Noe, G B Dole, et al.
Cancer Research|June 1, 1990
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazoleA Hantel, R C Donehower, E K Rowinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedulesE K Rowinsky, D A Noe, L B Grochow, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
RNA (New York, N.Y.)|November 27, 2001
Phosphorylation of the Saccharomyces cerevisiae La protein does not appear to be required for its functions in tRNA maturation and nascent RNA stabilizationK S Long, T Cedervall, C Walch-Solimena, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1989
Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteersT L Chen, G B Vogelsang, B G Petty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agentE K Rowinsky, G S Long, D A Noe, et al.
Cancer Research|February 15, 1995
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantationT L Chen, J L Passos-Coelho, D A Noe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Journal of the National Cancer Institute|December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexateA Hantel, E K Rowinsky, D A Noe, et al.
Journal of Medicinal Chemistry|March 4, 1998
The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactionsE M Shulman-Roskes, D A Noe, M P Gamcsik, et al.
Journal of the National Cancer Institute|January 18, 1989
Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamicsL B Grochow, D A Noe, G B Dole, et al.
Cancer Research|June 1, 1990
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazoleA Hantel, R C Donehower, E K Rowinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedulesE K Rowinsky, D A Noe, L B Grochow, et al.
Pageof 5